ATWLPPRC

A7RC is a multifunctional peptide used in tumor-targeted therapy, with Cysteine added to the C-terminal of the A7R peptide (sequence: ATWLPPR). A7R is a ligand of the NRP-1 receptor, regulating intracellular signal transduction related to tumor vascularization and tumor growth .


Cat. No.: EX-A17256	Purity: >98%

	Chemical structure of ATWLPPRC

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock	Quantity	Order

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	632358-46-4
Purity	>98%
Formula	C43H66N12O10S
Mol Weight	943.124
Color	White to off-white
State	Solid
Solubility	soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20°C, sealed storage, away from moisture; In solvent -20℃, 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Cao J, et al. A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomater Sci. 2015 Dec;3(12):1545-54.
CoA	CoA of ATWLPPRC

Smiles:	C([C@@H](C(N[C@H](C(=O)N1[C@H](C(=O)N2[C@H](C(N[C@H](C(N[C@H](C(O)=O)CS)=O)CCCNC(=N)N)=O)CCC2)CCC1)CC(C)C)=O)NC([C@@H](NC([C@H](C)N)=O)[C@@H](C)O)=O)C=3C=4C(NC3)=CC=CC4


		Search